Exploring Molecular Diagnostics: Validating a Multiplex STI Panel with Non-Invasive Sample Types

Join us at AMP 2023, where Dr.Vijay Singh, Vice President of HealthTrackRx, a leading molecular PCR-based infectious disease laboratory, will discuss the development and validation of a laboratory developed, multiplex real-time PCR test for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV) on two separate PCR platforms. He will show how the test displayed high accuracy, sensitivity, and specificity for the tested pathogens in different patient sample types. In addition, Dr. Singh will discuss the viability of using urine, a non-invasive sample type, for testing STIs.